Soliris (eculizumab) is a prescription drug used to treat certain rare autoimmune conditions. Soliris can cause side effects that range from mild to serious. Examples include headache and back pain.

It took longer than some industry watchers expected, but Alexion has another indication for lead med Soliris in the bag. On Monday, the company said the FDA had greenlighted the product to treat ...

In an effort to protect its blockbuster Soliris, Alexion has employed a double strategy of nabbing additional approvals and positioning follow-up drug Ultomiris to switch over sales. Alexion added ...

The cost of Soliris can vary based on several factors, including your insurance coverage. Drug savings programs can also lower the price you’ll pay for Soliris. Soliris may need to be purchased ...

The FDA approved a fourth indication for Alexion Pharmaceuticals’ brand-name eculizumab (Soliris) for the treatment of neuromyelitis optica spectrum disorder (NMOSD) in adult patients who are ...

Alexion's Soliris Granted Marketing Approval in Europe for Treatment of All Patients With PNH - First therapy approved in both Europe and the United States for rare and life-threatening blood disease ...

Soliris(R) (eculizumab), a terminal complement inhibitor developed by Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN), was observed by investigators to reduce blood measures associated with undiagnosed ...

(Reuters) - Apellis Pharmaceuticals Inc said on Tuesday its experimental drug for a blood disorder showed greater improvement in patients' hemoglobin levels than market leader Alexion Pharmaceuticals ...

- 98% of adult anti-aquaporin-4 (AQP4) antibody-positive patients treated with SOLIRIS were relapse free compared to 63% receiving placebo at 48 weeks - “We are pleased that the Japanese health ...

Alexion Pharmaceuticals, Inc.ALXN announced that Soliris has failed to meet the primary endpoint in a randomized, parallel-group, double-blind, placebo-controlled, multi-center phase II/III study ...